ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,876, issued on March 4, was assigned to Surrozen Operating Inc. (South San Francisco, Calif.).
"Liver-specific Wnt signal enhancing molecules and uses thereof" was invented by Yang Li (Mountain View, Calif.), Zhengjian Zhang (Albany, Calif.), Randall J. Brezski (Alameda, Calif.), Leonard Presta (San Francisco), Thomas Lopez (Palo Alto, Calif.), Hui Chen (Foster City, Calif.), Helene Baribault (Redwood City, Calif.), Wen-Chen Yeh (Belmont, Calif.) and Shengjiang Tu (Foster City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides liver-specific Wnt signal enhancing molecules, and related methods of using these molecu...